Tomoaki Terakawa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Metastatic Renal Cell Carcinoma

Community Dwelling

Radical Prostatectomy

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Japanese journal of clinical oncology

Investigative and clinical urology

This page only lists publications with an associated author ORCID identifier.

Publications

Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, Takuto Hara, Taisuke Tobe, Junichiro Hirata, Naoto Wakita, Yasuyoshi Okamura, Kotaro Suzuki, Yukari Bando, Koji Chiba, Jun Teishima, Yuzo Nakano, Hideaki Miyake
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53. The Prostate (2024)
Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Keisuke Okada, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Jun Teishima, Yuzo Nakano, Hideaki Miyake
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability. International journal of urology : official journal of the Japanese Urological Association (2024)
Takuto Hara, Junya Furukawa, Yusuke Shiraishi, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Ken-Ichi Harada, Yuzo Nakano, Masato Fujisawa
Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2023)
Hideto Ueki, Tomoaki Terakawa, Takuto Hara, Junichiro Hirata, Naoe Jimbo, Yasuyoshi Okamura, Yukari Bando, Junya Furukawa, Kenichi Harada, Yuzo Nakano, Masato Fujisawa
Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer. Japanese journal of clinical oncology (2023)
Takuto Hara, Tomoaki Terakawa, Yasuyoshi Okamura, Yukari Bando, Junya Furukawa, Kenichi Harada, Yuzo Nakano, Masato Fujisawa
Real-world analysis of metastatic prostate cancer demonstrates increased frequency of PSA-imaging discordance with visceral metastases and upfront ARAT/docetaxel therapy. The Prostate (2023)
Takuto Hara, Junya Furukawa, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Ken-Ichi Harada, Satoru Takahashi, Yuzo Nakano, Masato Fujisawa
The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion. International journal of urology : official journal of the Japanese Urological Association (2023)
Ken-Ichi Harada, Ryo Sato, Yukari Bando, Asuka Sano, Yuto Matsushita, Keita Tamura, Tomoaki Terakawa, Junya Furukawa, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan. International journal of urology : official journal of the Japanese Urological Association (2023)
Hideto Ueki, Takuto Hara, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Junya Furukawa, Ken-Ichi Harada, Yuzo Nakano, Masato Fujisawa
Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study. Investigative and clinical urology 63 (4) (2022)